Pharma group Actavis has upgraded and expanded its Malta facility to accommodate almost triple growth in volume in recent years. The firm worked with Extract Technology, a supplier of containment and aseptic systems for the pharma, healthcare, biotech and chemical markets, to complete the relocation project.
The investment into bigger warehousing facilities was due to a significant increase in the Bulebel site manufacturing output, where volume has practically tripled over the last 7 years.
Extract’s after market department won the two phase project through the supply of a set-up that incorporated the rental, installation and validation of a Temporary Sampling Down-flow booth, followed by the relocation and full validation of a two booth sampling facility with automated roller conveyors in the new warehouse.
Following a continuous three week site attendance of dismantling and reinstalling the facility including IQ, OQ documentation and Operator Exposure Level (OEL) reports, Extract Technology had relocated the sampling facility within the new warehouse.
After Market Manager Stephen Schofield said: “Working with Actavis the importance of the contract was highlighted at the initial site meeting with continual production throughout the relocation works a priority.
The contract was well executed from initial conception to final validation with both the Extract and Actavis installation teams working together to complete the contract within the scheduled timeframe and budget.”
Actavis Technical Project Manager, John Azzopardi said: “The relocation was handled in a very professional manner, Extract’s staff and personnel on site were instrumental in making it happen. The reinstallation was performed in the agreed schedule of works.”
